Abstract:Magnesium, an essential mineral micronutrient, plays a role in the activation of various transporters and enzymes. The present study aimed to investigate the possibility of applying magnesium to enhance the efficacy of cisplatin which is still ranked as one of the major chemotherapeutic drugs for bladder cancer patients. Results showed that the survival rate and colony formation of bladder cancer cells were reduced by combinatorial treatment with cisplatin and magnesium chloride (MgCl 2 ). The proportion of apoptotic cells was also increased in UC3 bladder cancer cells treated with a combination of cisplatin and MgCl 2 . Most importantly, a marked decrease in nuclear β-catenin was observed in cells that received cisplatin treatment. In addition, the nuclear β-catenin in cisplatin treated cells was further down-regulated by supplementing MgCl 2 . 6-bromoindirubin-3′-oxime (BIO), an inhibitor of glycogen synthase kinase-3 (GSK-3) that activates the Wnt/β-catenin signaling pathway by modulating β-catenin activity, was thus applied to further exploit the role of this signaling pathway in magnesium aided cancer treatment. The survival rate of bladder cancer cells was decreased by BIO treatment at concentrations of 1.0, 2.5 and 5.0 μM accompanied by increased β-catenin expression. However, the expression of β-catenin in MgCl 2 -treated cells was lower than in untreated cells under the same BIO concentration. The expression of cleaved caspase-3, cleaved caspase-9 and microtubule-associated protein 1 light chain 3- II (LC3-II) was highest in cells treated with MgCl 2 and 5.0 μM BIO among the examined groups. Our findings reveal that magnesium could contribute to cisplatin-based chemotherapy by moderately regulating the Wnt/β-catenin signaling pathway.

Biodegradable magnesium based metal materials inhibit the growth of cervical cancer cells

Magnesium alloys in tumor treatment: Current research status, challenges and future prospects

Cytotoxic Effect on Osteosarcoma MG-63 Cells by Degradation of Magnesium

A highly degradable Mg-Al-Ca alloy with superior anti-tumor efficacy

Cytotoxic Effects of Biodegradation of Pure Mg and MAO-Mg on Tumor Cells of MG63 and KB

On the Antitumor Properties of Biomedical Magnesium Metal

Degradable magnesium implants inhibit gallbladder cancer

Biodegradable magnesium alloy with eddy thermal effect for effective and accurate magnetic hyperthermia ablation of tumors

In situ engineered magnesium alloy implant for preventing postsurgical tumor recurrence

Biodegradable Magnesium Implants: a Potential Scaffold for Bone Tumor Patients

Magnesium Galvanic Cells Produce Hydrogen and Modulate the Tumor Microenvironment to Inhibit Cancer Growth

Biodegradable Magnesium Nanoparticle-Enhanced Laser Hyperthermia Therapy

Magnesium Metal--a Potential Biomaterial with Antibone Cancer Properties.

Effect and mechanism of magnesium isoglycyrrhizinate on the biological behavior of breast cancer cell lines

Concerting magnesium implant degradation facilitates local chemotherapy in tumor-associated bone defect

A Cellular Study on Cytotoxicity of Magnesium-calcium Alloy

Corrosion and Biological Performance of Biodegradable Magnesium Alloys Mediated by Low Copper Addition and Processing.

Degradable magnesium-based alloys for biomedical applications: The role of critical alloying elements

Magnesium-Assisted Cisplatin Inhibits Bladder Cancer Cell Survival by Modulating Wnt/β-Catenin Signaling Pathway

Biocorrosion and Cytotoxicity Studies on Biodegradable Mg-Based Multicomponent Alloys

Enhanced antimicrobial properties, cytocompatibility, and corrosion resistance of plasma-modified biodegradable magnesium alloys